Landscapes / Companies
Radiopharm Theranostics, Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
2 in Phase 1
Drugs
5
in active trials
Trials
5 active
5 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer and 9 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Nov 2028Phase 1/2 trial completes | |||
| Next date | 30 Nov 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Castration-resistant Prostate Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Brain Metastases From Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Aug 2027Phase 1 trial completes | |||
| Next date | 30 Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Imaging, Colorectal Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) and 4 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021